Eduard Vieta, MD, PhD

Bipolar and Depressive Disorders Unit, Hospital Clínic de Barcelona, Barcelona, Spain; Institute of Neurosciences (UBNeuro); Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Biomedical Research Networking Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III (ISCIII); Department of Medicine, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain

  • 74Articles
  • 315.9KReads1
  • 2000–2026Active
  • 273Collaborators
  • 2.6KCitations2

About

Eduard Vieta, MD, is affiliated with the Bipolar and Depressive Disorders Unit at Hospital Clínic de Barcelona and several research institutes in Barcelona, Spain. With over 70 publications since 2000, Vieta has contributed extensively to clinical research on bipolar disorder, schizophrenia and schizoaffective disorders, major depressive disorder, suicide, anxiety, eating disorders, neurology, and hepatitis. His work includes studies on diagnostic screening tools, predictors of psychosis onset, treatment modalities, and the impact of comorbid conditions on cognitive functioning. Frequent collaborators include Anabel Martínez-Arán, Francesc Colom, and Ana Gonzalez-Pinto.

Publications

JCP
Ketamine/Esketamine in Clinical Practice: Areas of Consensus and Non-consensus From an ASCP Task Force
Consensus Statement

Ketamine/Esketamine in Clinical Practice: Areas of Consensus and Non-consensus From an ASCP Task Force

November 2, 2026

The American Society of Clinical Psychopharmacology convened an expert task force to address questions about practical use of these agents in “real world” settings.
, , , et al
JCP
What Is Meant by the Term “Deprescribing,” and Does It Belong in Our Lexicon?
ASCP Corner

What Is Meant by the Term “Deprescribing,” and Does It Belong in Our Lexicon?

June 2, 2025

The authors encourage the field to destigmatize the term “deprescribing” from its misappropriated usage, explicate its accurate definition, and reclaim its purposeful meaning.
, , , et al
PCC
Screening for Bipolar Disorder and Evaluating the RMS
Original Research

Screening for Bipolar Disorder and Evaluating the RMS

April 25, 2023

Health care providers found the Rapid Mood Screener, a new bipolar I disorder screening tool, to be superior to the widely used Mood Disorder Questionnaire in sensitivity/specificity, brevity, practicality,...
, , , et al
JCP
Original Research

Predictors of Early-Onset vs Adult-Onset Psychosis

September 14, 2021

Most research on first-episode psychosis has focused on adults. This study aimed to explore differences in early-life characteristics of patients with early-onset versus those with adult-onset psychotic disorders and...
, , , et al
JCP
Original Research

Predictors of Bipolar Disorder in First Psychotic Episode

November 3, 2020

What features may predict bipolar disorder vs schizophrenia in a person with first-episode psychosis? In this journal CME activity, find out which tools could most aid diagnosis.
, , , et al
PCC
Original Research

Efficacy of Cariprazine in Bipolar Disorder

September 17, 2020

Bipolar disorder is characterized by a chronic and subtle course of fluctuating symptoms. To explore the efficacy of cariprazine across the symptoms of bipolar depression, post hoc analyses of...
, , , et al
JCP
Original Research

Bridging the Gap Between Mixed and Atypical Depression

February 19, 2019

Is there a common denominator between mixed depression and atypical depressive features? In this post hoc analysis of the BRIDGE-II-MIX Study, affective lability and mood reactivity were investigated in...
, , , et al
JCP
Review Article

Psychoeducation in the Management of Bipolar Disorder

May 1, 2018

A variety of pharmacologic agents are available for treating your patients with bipolar disorder, but have you considered adding psychoeducation to your armamentarium? This review summarizes the evidence on...
, , , et al
JCP
Article

Obesity and Cognition in Bipolar Disorder

October 3, 2017

Available data suggest that excess weight and obesity are associated with poorer cognitive functioning and numerous pathophysiologic changes in adults. This post hoc analysis sought to determine whether obesity...
, , , et al
JCP
Article

Persistent Negative Symptoms in First-Episode Psychosis

September 12, 2017

Although negative symptoms of psychosis may be less prominent than positive symptoms, they can still have an equally great impact on patient functioning. This study of patients with a...
, , , et al
JCP
Original Research

Mixed Features in Patients With a Major Depressive Episode: the BRIDGE-II-MIX Study

March 25, 2015

, , , et al
JCP
Meta-Analysis

Prophylactic Antidepressant Treatment of Interferon-Induced Depression in Chronic Hepatitis C: A Systematic Review and Meta-Analysis

October 28, 2014

, , , et al

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Insightful. Evidence-based. Human-centered.

Listen Now
Psychiatrist Steven Berkowitz, MD, discusses psychedelic medicine for trauma treatment

Subscribe to read
more articles

Subscribe